IL6 and asthma: Our results support research into the potential for targeting this pathway to treat allergic inflammatory conditions, such as severe asthma, while future research with larger numbers of COPD cases is needed to understand more fully the role of IL-6 trans-signaling and its associated pathways in the development of COPD.